Skip to main content

Advertisement

SpringerLink
Log in

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Yi JS, Guidon A, Sparks S, Osborne R, Juel VC, Massey JM et al (2014) Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. J Autoimmun 52:130–138

    Article  CAS  PubMed  Google Scholar 

  2. Roche JC, Capablo JL, Larrad L, Gervas-Arruga J, Ara JR, Sánchez A et al (2011) Increased serum interleukin-17 levels in patients with myasthenia gravis. Muscle Nerve 44(2):278–280

    Article  CAS  PubMed  Google Scholar 

  3. Xie Y, Li HF, Jiang B, Li Y, Kaminski HJ, Kusner LL (2016) Elevated plasma interleukin-17A in a subgroup of myasthenia gravis patients. Cytokine 78:44–46

    Article  CAS  PubMed  Google Scholar 

  4. Li Y, Guptill JT, Russo MA, Howard JF Jr, Massey JM, Juel VC et al (2020) Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis. J Neuroimmunol 345:577279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Evoli A, Alboini PE, Iorio R, Damato V, Bartoccioni E (2017) Pattern of ocular involvement in myasthenia gravis with MuSK antibodies. J Neurol Neurosurg Psychiatry 88(9):761–763

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Università Cattolica del Sacro Cuore, Rome, Italy

    Claudia Papi, Giuseppe Granata & Raffaele Iorio

  2. Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Giuseppe Granata & Raffaele Iorio

  3. Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy

    Marco Galluzzo

  4. Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, Italy

    Marco Galluzzo

Authors
  1. Claudia Papi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Granata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Galluzzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raffaele Iorio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raffaele Iorio.

Ethics declarations

Ethical approval

The participant has consented to the submission of the case report to the journal. Approval of this study was obtained from the ethics committee of the Catholic University of the Sacred Heart.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papi, C., Granata, G., Galluzzo, M. et al. Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor. Neurol Sci 44, 1105–1107 (2023). https://doi.org/10.1007/s10072-022-06498-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06498-7

Search

Navigation